VPD’s strategy is to create, invest in, and manage a portfolio of “project-focused companies,” each of which contains a single drug candidate acquired from a third party. VPD designs and executes the clinical development program for each of these drug candidates. VPD acquires rights to individual therapeutic drug candidates from biotechnology companies, pharmaceutical companies and academia, and invests in their development through clinical proof-of-concept (generally demonstration of human safety and efficacy in phase 2a trials). Following proof-of-concept, VPD seeks to sell each drug asset to a major pharmaceutical company.
There is a robust demand by pharmaceutical acquirers for products with key human clinical data. Our model provides partners with a compelling alternative strategy for the development of their drug candidates. By partnering with VPD, the owner of a drug candidate can achieve the funding needed to take the drug candidate to clinical proof-of-concept while accessing a world-class team to design and oversee the development program. The contributor of the drug candidate receives equity in the company created to house its drug program and benefits from the ultimate financial upside upon clinical success and sale of that company to a pharmaceutical company.
The Velocity model is much more efficient than traditional company-based drug development because it avoids the cost and time of building a separate management team and infrastructure around each program.
Company Details
- Employees
- 2
- Founded
- -
- Address
- 400 Oyster Point Boulevard,
- Phone
- 650-273-5748
- in****@****vpd.net
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- vpd.net
- Keywords
- World-Class Drug Development Team, Short Holding Period: Average of 3 Years, Creating Project-Focused Companies, Investing in Drug Candidates Through Proof of Concept, and We Build Drugs, Not Companies.
- HQ
- South San Francisco, CA
Velocity Pharmaceutical Development, Llc Questions
Velocity Pharmaceutical Development, Llc's helpline number is 650-273-5748
Velocity Pharmaceutical Development, Llc's website is vpd.net
Velocity Pharmaceutical Development, Llc's LinkedIn profile is https://www.linkedin.com/company/velocity-pharmaceutical-development
Velocity Pharmaceutical Development, Llc has
2 employees.
View email and phone details for 2
employees at Velocity Pharmaceutical Development, Llc.
Velocity Pharmaceutical Development, Llc's industry is
Pharmaceutical Manufacturing
Velocity Pharmaceutical Development, Llc's top competitors are
Synthonics, Inc.,
Velocity Pharma Llc,
X-37,
Octavius Pharmaceutical,
Care Pharmaceutical Ltd,
Cannjoin Innovation & Enterprise Inc.,
Covalent Laboratories Private Limited (Hyderabad),
Syntho Pharmaceuticals, Inc.,
North Of Tyne Local Pharmaceutical Committee (Lpc),
8vc.
Velocity Pharmaceutical Development, Llc's support email address is info@vpd.net
Velocity Pharmaceutical Development, Llc's categories are Pharmaceutical Manufacturing
Velocity Pharmaceutical Development, Llc's founding year is 2011
